Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.

The international journal of neuropsychopharmacology - 1 Oct 2007

Xing Qinghe, Qian Xueqing, Li Huafang, Wong Shiming, Wu Shengnan, Feng Guoyin, Duan Shiwei, Xu Mingqing, Gao Rui, Qin Wei, Gao Jianjun, Meng Junwei, He Lin

Abstract excerpt

Antipsychotic drugs exert both therapeutic and adverse effects through dopamine D2 receptor (DRD2) antagonism. Genetic variants of this receptor may be responsible for individual variations in neuroleptic response and may therefore be useful in predicting response. In this study we evaluated the role of six polymorphisms of the DRD2 gene in 125 risperidone-treated Chinese schizophrenia patients following the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chi-Square Distribution

Share to Linkage Disequilibrium

Share to Pharmacogenetics

Share to Receptors, Dopamine D2

Share to Risperidone

Share to Schizophrenia

Source

Identifiers

PMID: 17105675
DOI: 10.1017/S146114570600719X

Genes

DRD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.PMID 17105675Read ↗

D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.Semantic proximity Read ↗

Association of dopamine receptor D1 (DRD1) polymorphisms with risperidone treatment response in Chinese schizophrenia patients.Semantic proximity Read ↗

Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.Semantic proximity Read ↗

Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.Semantic proximity Read ↗

Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone.Semantic proximity Read ↗

Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response.Semantic proximity Read ↗

Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function.Semantic proximity Read ↗

Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.Semantic proximity Read ↗

DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs.Semantic proximity Read ↗

Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.Semantic proximity Read ↗

Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study.Semantic proximity Read ↗

Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.